Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 919-924     DOI: 10.31083/j.rcm2203099
Special Issue: Diet, nutrients and cardiovascular disease prevention
Original Research Previous articles | Next articles
Serum endothelin-1 level positively correlates with waist and hip circumferences in stable coronary artery disease patients
Anggoro Budi Hartopo1, *(), Jajah Fachiroh2, Ira Puspitawati3, Fatwa Sari Tetra Dewi4
1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada – Dr. Sardjito Hospital, 55281 Yogyakarta, Indonesia
2Department of Histology and Cell Biology, Faculty of Medicine, Public Health and Nursing - Biobank Development Team, Universitas Gadjah Mada, 55281 Yogyakarta, Indonesia
3Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada – Dr. Sardjito Hospital, 55281 Yogyakarta, Indonesia
4Department of Health Behavior, Environment and Social Medicine, Faculty of Medicine, Public Health and Nursing-Sleman Health and Demographic Surveillance System, Universitas Gadjah Mada, 55281 Yogyakarta, Indonesia
Download:  PDF(187KB)  ( 171 ) Full text   ( 18 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Central obesity is associated with increased level and activity of endothelin-1. The waist and hip circumferences are simple indicators of central obesity. Waist circumference correlates with visceral adiposity, whereas hip circumference associates with gluteofemoral peripheral adiposity. Both measurements have independent and opposite correlation with coronary artery disease (CAD) risk factors. The relation between serum endothelin-1 in stable CAD and both parameters of central obesityneeds to be investigated. This study aims to examine the correlation between serum endothelin-1 level and waist and hip circumferences as parameters of central obesity in patients with stable CAD. This was a cross-sectional study. Consecutive subjects were enrolled among those who underwent elective coronary angiography with significant CAD. Serum endothelin-1 was measured from peripheral blood samples taken before coronary angiography procedure. The measurement of waist circumference, hip circumference, and ratio derived from them, was performed. Central obesity was determined by waist circumference cut-off for Indonesian population. The correlation analysis was performed with Pearson test. The multivariate analysis was performed with multiple linear regression test. The comparison of serum endothelin-1 level between groups was performed with Student T test. We enrolled 50 subjects. The majority of subjects was male (80.0%), hypertensive (86.0%), dyslipidemic (68%) and smoker (52%). Most subjects had history of acute coronary syndrome (64%). Mean waist circumference was 87.6 +/– SD cm, hip circumference was 95.3 cm +/– SD, mean waist-to-hip ratio was 0.92 +/– SD and mean waist-to-height ratio was 0.54 +/– SD. Central obesity occurred in 32% of subjects. Mean serum endothelin-1 level was 2.2 ± 0.7 pg/mL. Serum endothelin-1 level tended to be higher in subjects with central obesity as compared to those without. Serum endothelin-1 level was significantly correlated with age, hemoglobin level, waist circumference (coefficient of 0.311, p value = 0.023) and hip circumference (coefficient of 0.359, p value = 0.010). Multivariable analysis indicated that age (coefficient of –0.353, p value = 0.007) and hip circumference (coefficient of 0.335, p value = 0.011) were independently correlated with serum endothelin-1. For conclusion, in patients with stable CAD, serum endothelin-1 was positively correlated with both waist circumference and hip circumference. Hip circumference independently and positively correlated with serum endothelin-1 level.
Key words:  Endothelin-1      Central obesity      Waist circumference      Hip circumference      Stable coronary artery disease     
Submitted:  09 February 2021      Revised:  23 April 2021      Accepted:  23 June 2021      Published:  24 September 2021     
Fund: 
2750/UN1.DITLIT/DIT-LIT/PT/2020/Deputi Bidang Penguatan Riset dan Pengembangan, Ministry of Research and Technology/National Research and Innovation Agency of Republic of Indonesia via Universitas Gadjah Mada
HK.02.03/XI.2/17234/2019/Dr. Sardjito Hospital
*Corresponding Author(s):  Anggoro Budi Hartopo     E-mail:  a_bhartopo@ugm.ac.id

Cite this article: 

Anggoro Budi Hartopo, Jajah Fachiroh, Ira Puspitawati, Fatwa Sari Tetra Dewi. Serum endothelin-1 level positively correlates with waist and hip circumferences in stable coronary artery disease patients. Reviews in Cardiovascular Medicine, 2021, 22(3): 919-924.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm2203099     OR     https://rcm.imrpress.com/EN/Y2021/V22/I3/919

[1] Xiao-Fei Wang, Meng-Cheng Xu, Cheng-Yu Mao, En-Zhou, Qing He, Xing-Qian Qu, Yu-Qi Fan, Chang-Qian Wang, Jun-Feng Zhang. Predictive and prognostic value of v-set and transmembrane domain-containing 1 expression in monocytes for coronary artery disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1009-1017.
[2] Andrea Saglietto, Vittorio Varbella, Andrea Ballatore, Henri Xhakupi, Gaetano Maria De Ferrari, Matteo Anselmino. Prognostic implications of atrial fibrillation in patients with stable coronary artery disease: a systematic review and meta-analysis of adjusted observational studies[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 439-444.
[3] Gao Wei, Ren Yaqi, Wang Ningfu, Hou Xuwei. N-terminal Prohormone B-type Natriuretic Peptide and Cardiovascular Risk in Stable Coronary Artery Disease: A Meta-analysis of Nine Prospective Studies[J]. Reviews in Cardiovascular Medicine, 2013, 14(2-4): 92-98.
[4] William B. Borden, Michael H. Davidson. Updating the Assessment of Cardiac Risk: Beyond Framingham[J]. Reviews in Cardiovascular Medicine, 2009, 10(2): 63-71.
[5] Anne L. Peters. Identification of Appropriate Patients for Cardiometabolic Risk Management[J]. Reviews in Cardiovascular Medicine, 2007, 8(S4): 9-16.
[6] Donna H. Ryan. The Relationship Among Risk Factor Clustering, Abdominal Obesity, and Residual Risk for Cardiovascular Events[J]. Reviews in Cardiovascular Medicine, 2007, 8(1): 9-16.
No Suggested Reading articles found!